Australia - engleză - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tramadol hydrochloride, quantity: 200 mg - tablet, modified release - excipient ingredients: hypromellose; hydrogenated castor oil; maize starch; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; lactose monohydrate; colloidal anhydrous silica; povidone; magnesium stearate; sodium starch glycollate; colour - tramadol sandoz sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramadol sandoz sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramadol sandoz sr is not indicated as an as-needed (prn) analgesia.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tramadol hydrochloride, quantity: 150 mg - tablet, modified release - excipient ingredients: sodium starch glycollate; lactose monohydrate; colloidal anhydrous silica; maize starch; hypromellose; microcrystalline cellulose; magnesium stearate; povidone; calcium hydrogen phosphate dihydrate; hydrogenated castor oil; colour - tramadol sandoz sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramadol sandoz sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramadol sandoz sr is not indicated as an as-needed (prn) analgesia.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tramadol hydrochloride, quantity: 100 mg - tablet, modified release - excipient ingredients: hypromellose; lactose monohydrate; calcium hydrogen phosphate dihydrate; magnesium stearate; sodium starch glycollate; hydrogenated castor oil; povidone; microcrystalline cellulose; maize starch; colloidal anhydrous silica; colour - tramadol sandoz sr is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. tramadol sandoz sr is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. tramadol sandoz sr is not indicated as an as-needed (prn) analgesia.

Malta - engleză - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - paracetamol, tramadol hydrochloride - film-coated tablet - paracetamol 325 mg tramadol hydrochloride 37.5 mg - analgesics

Australia - engleză - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - tramadol hydrochloride, quantity: 37.5 mg; paracetamol, quantity: 325 mg - tablet, effervescent - excipient ingredients: povidone; sunset yellow fcf; saccharin sodium; citric acid; sodium bicarbonate; macrogol 6000; acesulfame potassium; sodium dihydrogen citrate; colloidal anhydrous silica; magnesium stearate; flavour - zaldiar is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - paracetamol, quantity: 325 mg; tramadol hydrochloride, quantity: 37.5 mg - tablet, film coated - excipient ingredients: powdered cellulose; magnesium stearate; macrogol 6000; sodium starch glycollate type a; titanium dioxide; hypromellose; pregelatinised maize starch; purified talc; iron oxide yellow; lactose monohydrate; maize starch; propylene glycol - zaldiar is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

amneal pharma europe limited - tramadol hydrochloride; paracetamol - film-coated tablet - 37.5/325 milligram(s) - other opioids; tramadol, combinations

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

generics (uk) limited - tramadol hydrochloride; paracetamol 90% dcl (compap l) - film-coated tablet - 37.5/325 milligram(s) - opioids in combination with non-opioid analgesics; opiods in combination with non-opiod analgesics

Irlanda - engleză - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - tramadol hydrochloride, paracetamol - film coated tablet - 37.5/325 milligram - opiods in combination with non-opiod analgesics

Australia - engleză - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - paracetamol,tramadol hydrochloride -